Lv32
300 积分 2023-03-29 加入
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
7个月前
已完结
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
7个月前
已完结
Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors
9个月前
已完结
Naturally available hypericin undergoes electron transfer for type I photodynamic and photothermal synergistic therapy
9个月前
已完结
A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B
10个月前
已完结
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
10个月前
已完结
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
10个月前
已完结
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
10个月前
已完结
A Personal History of Photodynamic Therapy
11个月前
已完结
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
1年前
已完结
皖公网安备34019202002308
